Menopause Strategies: Finding Lasting Answers for Symptoms and Health: Efficacy of a Selective Serotonin Reuptake Inhibitor (SSRI) for Menopausal Symptoms in Midlife Women.

Trial Profile

Menopause Strategies: Finding Lasting Answers for Symptoms and Health: Efficacy of a Selective Serotonin Reuptake Inhibitor (SSRI) for Menopausal Symptoms in Midlife Women.

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Jul 2014

At a glance

  • Drugs Escitalopram (Primary)
  • Indications Hot flashes; Menopausal syndrome
  • Focus Therapeutic Use
  • Acronyms MsFLASH-01
  • Most Recent Events

    • 01 Mar 2012 Results of the sexual function analysis published in Obstetrics and Gynecology.
    • 24 Sep 2011 Results assessing sleep quality and insomnia symptoms presented at the 22nd Annual Meeting of the North American Menopause Society.
    • 09 Oct 2010 Results were presented at the 21st Annual Meeting of the North American Menopause Society.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top